Skip to main content

Table 2 Baseline characteristics of CLL patients

From: miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies

  All Patients BCL-XL < median   BCL-XL > median   P
(n = 38) (n = 38)
  Number Value (range) Number Value (range) No. (%) Value (range)
Age, median (range), years   64 (38–90)   64.5 (38–90)   64 (48–87) N.S.
Sex, male/female 52/24   22/16   30/8   0.08
Rai Stage N = 76       
 Early (Stage 0/I/II) 59   36   23   
 Advanced (Stage III/IV) 17   2   15   
Zap70 positive 18 of 44   11 of 24   7 of 20   0.937
CD38 positive 22 of 53   10 of 27   12 of 26   0.110
FISH        
 17p 7 of 35   1 of 19   6 of 16   0.275
 11q 6 of 35   4 of 19   2 of 16   0.666
 13q14 22 of 35   12 of 18   10 of 17   0.733
 Trisomy 12 6 of 35   2 of 17   4 of 16   0.398